AMZN
Amazon.com, Inc.
AMZN's fundamentals are mixed: revenue grew 15%, but free cash flow turned negative. Its PE of 22x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect strong earnings growth.
LTH
Life Time Group Holdings, Inc.
LTH's fundamentals are strong and it looks cheap: trading at 25x earnings, below its usual 36x. Analysts expect strong earnings growth.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
LTH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Weak | |
| Healthy |
LTH's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over LTH in the historical PE scenario, which offers more potential upside but is not a forecast.
LTH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $41.05 | -9.9% |
| Current | 25x | $45.54 | — |
| Forward | 26x | $45.54 | — |
| Fair | 35x | $65.25 | +43% |
| Expensive | 46x | $85.57 | +88% |
Historical ranges are pointers, not guarantees.
LTH's PE is in its cheap range at 25x. On analysts' estimates for next year's earnings, today's price would be 26x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
LTH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
LTH has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN's earnings per share have climbed steadily: $12.37 over the past year, up 75% from the year before, and higher year over year for 14 quarters in a row. Its recent earnings include one-off gains.
LTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.76 | -4.6% |
| Q3 2026 | $1.85 | +45% |
| Q2 2026 | $1.84 | +80% |
| Q1 2026 | $1.71 | +78% |
| Q4 2025 | $1.66 | +124% |
| Q3 2025 | $1.28 | +88% |
| Q2 2025 | $1.02 | +92% |
| Q1 2025 | $0.96 | +174% |
| Q4 2024 | $0.74 | +100% |
LTH has the edge over AMZN on earnings, with stronger typical year-over-year growth.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
LTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $893.5M | +14% |
| Q2 2026 | $866M | +14% |
| Q1 2026 | $788.7M | +12% |
| Q4 2025 | $745.1M | +12% |
| Q3 2025 | $782.6M | +13% |
| Q2 2025 | $761.5M | +14% |
| Q1 2025 | $706M | +18% |
| Q4 2024 | $663.3M | +19% |
LTH has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | +0.4 points |
| Q2 2026 | 17% | +3 points |
| Q1 2026 | 17% | +1.9 points |
| Q4 2025 | 17% | +4.3 points |
| Q3 2025 | 17% | +3.8 points |
| Q2 2025 | 14% | -1.4 points |
| Q1 2025 | 15% | +3.2 points |
| Q4 2024 | 13% | +2.6 points |
LTH has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
LTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$26.6M | -193% |
| Q2 2026 | -$53.7M | -$27.4M |
| Q1 2026 | -$61.2M | -248% |
| Q4 2025 | -$64.6M | -341% |
| Q3 2025 | $28.6M | -55% |
| Q2 2025 | -$26.3M | -201% |
| Q1 2025 | $41.4M | +$107.8M |
| Q4 2024 | $26.8M | +$62.9M |
LTH has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over LTH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
LTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +1.7M shares |
| 1 year | +1.3% | +3M shares |
| 3 years | +12% | +24.8M shares |
| 5 years | +58% | +83.9M shares |
| Available history | +58% | +84.1M shares |
LTH has 229M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $62.7M |
| Q1 2026 | $10.7M |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over LTH on leverage, with a lower net debt burden relative to earnings.
LTH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.4x | Moderate |
LTH's net debt is about 1.3 years of its operating earnings (EBITDA), down from 1.8 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
LTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.6 | Neutral |
| Stochastic | 80.6 | Overbought |
LTH's weekly RSI is 66 (neutral) and its Stochastic is 81 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over LTH on valuation relative to its sector.
LTH PE vs Consumer Cyclical Sector
| Metric | LTH | Sector median | Relative |
|---|---|---|---|
| PE | 25x | 18x | 37% above |
| PE % | 28 | 56 | 28 pts below |
LTH is trading at 25x earnings, a 37% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
LTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.7 | 6.6% above |
| 20 week MA | $42.9 | 6.3% above |
| 50 week MA | $34.7 | 31% above |
| 100 week MA | $31.5 | 45% above |
| 200 week MA | $24.8 | 84% above |
LTH is in an uptrend: it's above all five of its weekly moving averages, and 84% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
LTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.2 | $18.1 | +5.1% |
| 2022 | $18.1 | $12.1 | -33% |
| 2023 | $12.1 | $15.1 | +24% |
| 2024 | $15.1 | $21.9 | +45% |
| 2025 | $21.9 | $26.8 | +22% |
| 2026 YTD | $26.8 | $45.5 | +70% |
LTH has the edge over AMZN on returns for 2026, with the stronger performance.